- Filed
- Feb 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 7, 2025 | 18.45M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $24.41M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $23.84M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $1.46M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $9.35M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $1.77M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $9.7M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $24.68M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $24.05M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $25.69M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $25.21M |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $2.53M |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $4.61M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $2.25M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $4.2M |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 3.82M sh |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 3.74M sh |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$18.09M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $7.49M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $7.55M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $15.34M |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$2.20 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$5.10 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$2.20 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$5.10 |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $6.47M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $15.35M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$8.4M |
| Net Income | Q2 2025 · Sep 30, 2023 | −$10.71M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$8.78M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$19.66M |